Insider Trading & Ownership - LENZ Therapeutics Inc. (LENZ)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for LENZ Therapeutics Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-05-14
Purchase
2024-05-15
4:13 pm
LENZ Therapeutics Inc.LENZChevallard Daniel R.
Chief Financial Officer
3,188$15.68$49,9883,188
(Direct)
View
2024-05-13
Purchase
2024-05-14
5:29 pm
LENZ Therapeutics Inc.LENZMCCOLLUM JAMES W
Director
31,332$15.99$501,093620,599
(Indirect
Direct)
View
2024-03-21
Purchase
2024-03-25
8:48 pm
LENZ Therapeutics Inc.LENZRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
998,009$15.03$15,000,075792,288
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2024-03-28
4:31 pm
N/A
N/A
LENZ Therapeutics Inc.LENZAlpha Wave Ventures GP Ltd
Alpha Wave Global LP
Lunate Holding RSC Ltd
Chimera Investment LLC
10% Owner
0$03,612,211
(Indirect)
View
2024-03-21
Option Award
2024-03-25
8:48 pm
2024-03-21
2027-10-30
LENZ Therapeutics Inc.LENZRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
3,343,318$0792,288
(Indirect)
View
2024-03-21
Option Award
2024-03-25
8:44 pm
N/A
2034-03-20
LENZ Therapeutics Inc.LENZThunen Shelley B
Director
27,000$027,000
(Direct)
View
2024-03-21
Option Award
2024-03-25
8:42 pm
N/A
N/A
LENZ Therapeutics Inc.LENZMCCOLLUM JAMES W
Director
16,633$15.03622,842
(Indirect)
View
2024-03-21
Option Award
2024-03-25
8:42 pm
2020-10-30
2027-10-30
LENZ Therapeutics Inc.LENZMCCOLLUM JAMES W
Director
606,209$0622,842
(Indirect)
View
2024-03-21
Option Award
2024-03-25
8:40 pm
N/A
2031-09-16
LENZ Therapeutics Inc.LENZGuerard Frederic
Director
81,468$081,468
(Direct)
View
2024-03-21
Option Award
2024-03-25
8:40 pm
N/A
2034-03-20
LENZ Therapeutics Inc.LENZScheiner Zachary
Director
27,000$027,000
(Direct)
View
2024-03-21
Option Award
2024-03-25
8:39 pm
N/A
2034-03-20
LENZ Therapeutics Inc.LENZDrapkin Kimberlee C
Director
27,000$027,000
(Direct)
View
2024-03-21
Option Award
2024-03-25
8:38 pm
N/A
2034-03-20
LENZ Therapeutics Inc.LENZGeorge Jeffrey P.
Director
27,000$027,000
(Direct)
View
2024-03-21
Option Award
2024-03-25
8:36 pm
N/A
2034-03-20
LENZ Therapeutics Inc.LENZChevallard Daniel R.
Chief Financial Officer
200,000$0200,000
(Direct)
View
2024-03-21
Option Award
2024-03-25
8:34 pm
N/A
2031-08-18
LENZ Therapeutics Inc.LENZOlsson Shawn
Chief Commercial Officer
254,355$0254,355
(Direct)
View
2024-03-21
Option Award
2024-03-25
8:33 pm
N/A
2033-06-19
LENZ Therapeutics Inc.LENZOdrich Marc
Chief Medical Officer
271,071$0271,071
(Direct)
View
2024-03-21
Option Award
2024-03-25
8:32 pm
N/A
2031-03-07
LENZ Therapeutics Inc.LENZSchimmelpennink Evert B.
President, CEO and Secretary
1,260,693$01,260,693
(Direct)
View
2024-03-21
Other
2024-03-25
4:30 pm
N/A
N/A
LENZ Therapeutics Inc.LENZVersant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage II L.P.
Versant Vantage II GP L.P.
Versant Vantage II GP-GP LLC
Versant Venture Capital VII L.P.
Versant Ventures VII GP L.P.
Versant Ventures VII GP-GP LLC
10% Owner
598,203$05,140,353
(Indirect)
View

Ownership
2024-03-25
4:19 pm
N/A
N/A
LENZ Therapeutics Inc.LENZVersant Venture Capital VII L.P.
Versant Ventures VII GP L.P.
Versant Ventures VII GP-GP LLC
10% Owner
0$01,669,323
(Direct)
View
2023-07-28
Option Award
2023-08-01
8:09 pm
N/A
2033-07-27
Graphite Bio Inc.GRPHDrapkin Kimberlee C
Director
40,000$040,000
(Direct)
View
2023-07-19
Option Award
2023-07-21
5:13 pm
N/A
2033-07-18
Graphite Bio Inc.GRPHViney Joanne L.
Director
20,000$020,000
(Direct)
View
2023-07-19
Option Award
2023-07-21
5:12 pm
N/A
2033-07-18
Graphite Bio Inc.GRPHPorteus Matthew
Director
20,000$020,000
(Direct)
View
2023-07-19
Option Award
2023-07-21
5:10 pm
N/A
2033-07-18
Graphite Bio Inc.GRPHKARSEN PERRY A
Director
20,000$020,000
(Direct)
View
2023-07-19
Option Award
2023-07-21
5:08 pm
N/A
2033-07-18
Graphite Bio Inc.GRPHJIMENEZ JOSEPH
Director
20,000$020,000
(Direct)
View
2023-07-19
Option Award
2023-07-21
5:07 pm
N/A
2033-07-18
Graphite Bio Inc.GRPHJerel Davis
Director
20,000$020,000
(Direct)
View
2023-07-19
Option Award
2023-07-21
5:05 pm
N/A
2033-07-18
Graphite Bio Inc.GRPHCarlo Rizzuto
Director
20,000$020,000
(Direct)
View
2023-07-19
Option Award
2023-07-21
5:02 pm
N/A
2033-07-18
Graphite Bio Inc.GRPHBassan Abraham
Director
20,000$020,000
(Direct)
View
2023-07-19
Option Award
2023-07-21
5:01 pm
N/A
2033-07-18
Graphite Bio Inc.GRPHShah Smital
Director
20,000$020,000
(Direct)
View
2023-07-19
Option Award
2023-07-21
5:00 pm
N/A
2033-07-18
Graphite Bio Inc.GRPHHege Kristen
Director
20,000$020,000
(Direct)
View
2023-02-21
Option Award
2023-02-23
5:04 pm
N/A
2033-02-20
Graphite Bio Inc.GRPHYoung Alethia
Chief Financial Officer
220,000$0220,000
(Direct)
View
2023-02-21
Option Award
2023-02-23
5:02 pm
N/A
2033-02-20
Graphite Bio Inc.GRPHLehrer-Graiwer Joshua
PRESIDENT AND CEO
600,000$0600,000
(Direct)
View

Ownership
2023-01-06
9:30 pm
N/A
N/A
Graphite Bio Inc.GRPHEcoR1 Capital LLC
10% Owner
0$08,538,446
(Indirect)
View
Goto 0, 1, 2, Next